Home » Topics » Regulatory

Regulatory
RSS

Losartan for treatment of erectile dysfunction

May 24, 1996

MacroChem's erectile dysfunction therapy moves to phase I/II in U.S.

May 24, 1996

Lovastatin potential for use in post-transplant patients

May 24, 1996

Transdermal scopolamine studied in hypertensive patients

May 24, 1996

Crixivan pediatric formulation in development

May 24, 1996

Amlexanox approvable in U.S.

May 24, 1996

Propecia NDA filing slated for late 1996

May 24, 1996

Zaprinast claimed for treatment of renal failure

May 17, 1996

FK-409 claimed as portal hypertension Rx

May 17, 1996

Pentoxifylline claimed for treating cold symptoms

May 17, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
GT-02897 exerts efficacy in preclinical multiple myeloma
BioWorld Science
Investigators from the Karl Landsteiner University aimed to evaluate the therapeutic potential of a novel CDK9 inhibitor/degrader, GT-02897, for the potential...